Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill

Sponsor

Mayo Clinic (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT04755777

Collaborator

(none)

138

Enrollment

Locations

26.3

Anticipated Duration (Months)

Patients Per Site

1.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.

Condition or Disease	Intervention/Treatment	Phase
Sepsis Critical Illness

Study Design

Study Type:

Observational

Anticipated Enrollment :

138 participants

Observational Model:

Other

Time Perspective:

Cross-Sectional

Official Title:

Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill: a Multicenter Mixed-methods Study

Actual Study Start Date :

Oct 22, 2020

Anticipated Primary Completion Date :

Dec 31, 2022

Anticipated Study Completion Date :

Dec 31, 2022

Outcome Measures

Primary Outcome Measures

Frequency of drug level testing recommended [Baseline]
Indication of how many critically ill patients treated with beta-lactams should receive TDM.
Nature of drug level testing recommended [Baseline]
Indication of which types of critically ill patients treated with beta-lactams should receive TDM

Secondary Outcome Measures

Determinants of beta-lactam TDM implementation [Baseline]
List of factors associated with successful beta-lactam TDM implementation

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Providers involved with beta-lactam TDM for critically ill patients

Exclusion Criteria:

None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	UF Health Shands	Gainesville	Florida	United States	32610
2	Mayo Clinic	Rochester	Minnesota	United States	55902
3	Royal Brisbane and Women's Hospital	Herston	Queensland	Australia	4029